StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 925.00
-10.00 (-1.07%)
Sep 10, 2025, 2:43 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 9.58 billion as of September 9, 2025. Its market cap has decreased by -41.56% in one year.
Market Cap
9.58B
Enterprise Value
7.36B
Revenue
2.70B
Ranking
n/a
PE Ratio
38.22
Stock Price
925.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 9.58B, a decrease of -54.72%. That is a compound annual growth rate of -17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 9.58B | -27.46% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.09T |
| Takeda Pharmaceutical Company | 7,049.28B |
| HOYA Corporation | 7,042.89B |
| Daiichi Sankyo Company | 6,811.47B |
| Otsuka Holdings | 4,495.45B |
| Terumo | 3,855.79B |
| Astellas Pharma | 3,034.58B |
| Shionogi & | 2,281.06B |